Tera J. Stone

Represented Astellas Pharma Inc. in Hatch-Waxman litigation against numerous generic manufacturers related to Astellas’s Myrbetriq® used to treat overactive bladder. Following a bench trial victory against Ascent Pharmaceuticals, the team was recognized as runners-up in The American Layer’s “Litigator of the Week.”

Represented multiple oilfield services companies against a major competitor regarding allegedly owed patent royalties. Prevailed at summary judgment on multiple grounds, ending a royalty tax that the adversary argued went for an additional decade and that in the prior decade was publicly reported to have resulted in over $1 billion of royalties to the adversary across the industry. Recognized as runners-up for The American Lawyer’s “Litigator of the Week.”

Represented iRobot Corporation in a successful Section 337 Investigation at the International Trade Commission (Inv. No. 337-TA-1252) as well as related district court litigation and co-pending inter parties review proceedings. Obtained a finding of infringement, resulting in the issuance of an exclusion order against certain SharkNinja robotic floor cleaners. The victory was highlighted in The American Layer, twice resulting in runners-up recognition for “Litigator of the Week.”

Represented Abbott Diabetes Care in global litigation against DexCom related to continuous glucose monitoring devices for individuals with diabetes. Secured a jury trial win on several claims in 2023. The parties reached a global settlement in 2024.

Represented Farmers Edge in the District of Nebraska against a direct competitor asserting patent infringement. After obtaining key admissions throughout discovery, the Court granted summary judgment that the patents were directed to ineligible subject matter under § 101 weeks before the scheduled trial.

Represented a leading energy and technology company in a multi-year, high-stakes arbitration that resulted in key legal wins and a significant financial award in the client’s favor in the final award.

Represented Actavis Laboratories in an appeal before the Federal Circuit concerning a treatment for Parkinson’s disease. Obtained a ruling from the court of appeals affirming the district court’s judgement that all challenged claims were invalid as obvious.

Associate, Kirkland & Ellis LLP, Chicago, 2017–2019

IP Legal Intern, ExxonMobil Chemical Company, Houston, 2015

Tera was recognized on the 2025 Capital Pro Bono Honor Roll.

Pro bono counsel in § 1983 action seeking redress for violations of prisoner’s Eighth Amendment rights to adequate medical care.

Pro bono counsel representing a veteran before the Department of Veterans Affairs seeking benefits.

Pro bono counsel representing parents of a child with disabilities seeking appropriate special education accommodations.